Breaking News

Almac Group Expands Commercial Manufacturing, Packaging, and Peptide Production Capacity

Two new purpose-built facilities at the CDMO’s headquarters are part of an ongoing global expansion investment that now totals over $500 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Almac Group has announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland meeting client demand in commercial manufacturing and packaging as well as peptide production. The multi-million-dollar large-scale expansion grows operations for two of the group’s business units, Almac Pharma Services and Almac Sciences. The first of these two major projects is a 32,000 square foot custom-built high-volume facility for Almac Pharma Services ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters